Abstract
The intrathecal administration of baclofen by way of an implanted subcutaneous drug delivery system is described in a patient with a severe spastic paraparesis due to multiple sclerosis. Intrathecally-administered baclofen is proposed as another therapeutic dimension and adjunct to physical therapy in the management of patients with severe spasticity that is unresponsive to antispasticity agents administered by mouth.
| Original language | English |
|---|---|
| Pages (from-to) | 465-466 |
| Number of pages | 2 |
| Journal | Medical Journal of Australia |
| Volume | 145 |
| Issue number | 9 |
| Publication status | Published - 3 Nov 1986 |